Investor Relations ; Events & Presentations · Upcoming events · Presentations ; FINANCIALS & FILINGS · SEC Filings · Annual Reports & Proxy Materials ; Stock ...
Mar 14, 2024. Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development · Mar ...
Media/Investor Relations Contacts: Zafgen, Inc. Patricia Allen Chief Financial Officer 617-648-9792. Media Krystle Gibbs Ten Bridge Communications
Ermenegildo Zegna Group to Report 2023 Full Year Financial Results, April 5, 2024 ... Investor relations contact details. Paola Durante. paola.durante@zegna.com.
Missing: zfgn | Show results with:zfgn
Media/Investor Relations Contacts: Zafgen, Inc. Patricia Allen. Chief Financial Officer. 617-648-9792. Media. Krystle Gibbs. Ten Bridge Communications. krystle ...
Media/Investor Relations Contacts: Zafgen, Inc. Patricia Allen. Chief Financial Officer. 617-648-9792. Media. Krystle Gibbs. Ten Bridge Communications. krystle ...
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
(Nasdaq:ZFGN). The combined, publicly traded ... Previous Ticker Symbol: ZFGN Changed: 1/01/00. Previous Name ... Company's Investor Relations Information, Goto ...
Exact name of registrant as specified in its charter - SEC.gov
www.sec.gov › data › zfgn-10k_20191231
Zafgen, Inc. 3 Center Plaza, Suite 610. Boston, Massachusetts 02108. (Address of principal executive offices, including zip code). Registrant's Telephone Number ...
Larimar Therapeutics (LRMR) Investor Presentation - Slideshow ... Zafgen (ZFGN) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow.
Missing: relations | Show results with:relations